US allows 1st emergency use of a COVID-19 antibody drug

WASHINGTON (AP) — U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19.

The Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.

Tests of it are continuing, but the drug does not seem to help patients with more serious illness.

It is similar to a treatment President Donald Trump received after contracting the virus last month.

The government previously reached an agreement to buy and supply much of the early production of the drug.

Share this article: